| Detailed information |
|---|
| CancerLivER ID | 2482 |
| Biomarker | COMT |
| Biomarker Name/Symbol (given in Publication) | catechol O-methyltransferase (COMT) |
| Biomolecule | Protein |
| Subject | Human |
| Degree of Validity | Potential biomarker for HCC and down-regulated in HCC tissues in HCC tumor than non-tumor; but not validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCC tissues in HCC tumor than non-tumor |
| Level of significance | p < 0.01 |
| Source | Tissue |
| PMID | 17627933 |
| Type of Biomarker | Diagnostic |
| Pathway | |
| Cohort | 12 paired tumor and nontumor tissues from HBV-associated HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2007 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |